Open original FDA record ↗Recall record
- FDA identifier
- Z-2434-2019
- Company in FDA record
- Helena Laboratories, Inc.
- FDA record creation date
- Aug 30, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range.
Source facts
- Action
- Between 10/14/2016 to 10/21/2016 a notification was emailed to the affected users informing them that Assay protocol had changed due to a Marketing decision to delete use of EDC, since it was a discontinued device (for over 10 years), creating a tighter assay range, but met QC specification. Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range, Technical Services began an MRA investigation. Investigation verified user complaint, and Lot was quarantined, and Rework action plans using EDC also were initiated for the device. This issue was found at a Users site, via use as system Quality Control material. The investigation focused on potential effects/risks, and cause. This issue was found at a Users site, via use as system Quality Control material. Customers reported a narrow assay range when compared to prior lots forcing some users out of the provided assay range. PUBLIC CONTACT: Title: Technical Services Manager Address: 1530 Lindbergh Drive, Beaumont, TX 77707 Telephone #: (409) 842-3714 x1177 Email: jhanka@helena.com
- Initiated
- 2016-10-14
- Root cause
- Process control
- Terminated
- 2023-10-12
- Distribution
- Domestic: FL, IL, MN, MT, NY, OH, TN, TX, VA, and WI OUS: Australia, Canada, Jordan, and South Korea
- Recall number
- Z-2434-2019
- Recall status
- Terminated
- CDRH record ID
- 168437
- FDA record created
- 2019-08-30
- Recall event number
- 81383